Oncology

Results from a post-hoc analysis of the phase 3 TROPION-Lung01 trial (NCT04656652) shared at the International Association for the Study of Lung Cance...

Chen et al. demonstrate that DNASE1L3+ dendritic cells degrade neutrophil extracellular traps, thereby facilitating CD8+ T cell infiltration, effector...

Invasion along nerves is prognostically detrimental in pancreatic and other cancers, yet its microenvironmental composition in humans remains poorly u...

In this issue of Cancer Cell, Chen et al. identify DNASE1L3-expressing dendritic cells (DCs) as enhancers of anti-tumor immunity. By degrading neutrop...

Macrophages naturally infiltrate tumors, modulate tumor microenvironment, phagocytose tumor cells, and present antigens to induce T cell responses. Th...

In this episode, CancerNetwork® spoke with Joseph S. Wallins, MD, MPH, cardiology fellow at Weill Cornell Medicine, about a review of cardiotoxicities...

Bispecific antibodies in multiple myeloma are currently approved for patients who have undergone at least 4 prior lines of therapy, but their use is r...

Video content above is prompted by the following: Pembrolizumab plus axitinib emerged as the first FDA-approved IO-TKI combination for first-line clea...

Video content above is prompted by the following: CheckMate 9ER established nivolumab plus cabozantinib as a potent immunotherapy-tyrosine kinase inhi...

In an interview with CancerNetwork® on nutrition in cancer treatment, Denise B. Reynolds, registered dietitian at Atrium Health Levine Cancer, discuss...